No Picture
News

Sophiris Bio To Shut Down Operations

SAN DIEGO and VANCOUVER, British Columbia, May 18, 2020 /PRNewswire/ — Sophiris Bio Inc. (OTCQB: SPHS) (the “Company” or “Sophiris”), today announced that its board of directors has formally approved an immediate shutdown of the operations of the C… […]

No Picture
News

STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies

STI-1499 Antibody has demonstrated in preclinical experiments (full results will be submitted to a peer-reviewed publication shortly):- 100% inhibition of SARS-CoV-2 virus infection of healthy cells after four days incubation- Specific binding to S1 su… […]

No Picture
News

Vividion Therapeutics to Present Data on Novel Covalent E3 Ligase Engager Supporting Broad Targeted Protein Degradation at 2020 AACR Annual Meeting

First Reported E3 Ligase Beyond Cereblon and VHL Shown to Support Broad Targeted Protein Degradation of Multiple Targets In Vivo

SAN DIEGO, May 15, 2020 /PRNewswire/ — Vividion Therapeutics, a biotechnology company discovering and developing highly … […]

No Picture
News

Neurocrine Biosciences to Present at the RBC Capital Markets 2020 Global Healthcare Conference

Live Webcast will be on May 19, 2020

SAN DIEGO, May 14, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the RBC Capital Markets 2020 Global Healthcare Conference at 3:40 p.m. ET on Tuesday, May 19, 2020. Kevin Gorman,… […]

No Picture
News

Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes

– Data to be Featured in the American Society of Clinical Oncology Annual 2020 Virtual Scientific Program on May 29, 2020 at 8:00 a.m. EDT –

LUGANO, Switzerland and SAN DIEGO, May 13, 2020 /PRNewswire/ — Helsinn Group, a Swiss pharmaceutical group f… […]

No Picture
News

DTx Pharma Receives Prestigious Funding Award to Support Research in Neurodegenerative Diseases of the CNS

-DTx was one of 8 grantees selected out of more than 100 academic and company applicants worldwide-

SAN DIEGO, May 13, 2020 /PRNewswire/ — DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat … […]

No Picture
News

Cardiff Oncology Enters Agreement with PoC Capital to Fund Phase 2 Clinical Trial of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)

– Funding will also enable the addition of new trial sites to accelerate completion of the Phase 2 clinical trial- Data continues to demonstrate the safety and efficacy of onvansertib as a promising new treatment for patients with KRAS-mutated mCRC

S… […]

No Picture
News

DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates

SAN DIEGO, May 13, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced its financial results for the thre… […]

No Picture
News

Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting

SAN DIEGO, May 12, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced a change to it… […]